Drug | Tablet
Metformin 500 mg (as sustained/extended release) + Gliclazide 80 mg (immediate release)
Type 2 diabetes mellitus to control blood sugar when diet/exercise and single therapy are insufficient
Metformin decreases glucose production in the liver and improves insulin sensitivity. Gliclazide (a sulfonylurea) increases insulin release from pancreatic beta cells, lowering blood sugar.
Take with meals as prescribed (often once or twice daily depending on formulation). Do not crush/chew sustained-release metformin tablets. Do not skip meals to reduce risk of hypoglycaemia; monitor blood glucose.
Common side effects of Dianorm M Tablet may include:
Risk of low blood sugar due to gliclazide, especially with irregular meals, alcohol, or other antidiabetics. Metformin rarely may cause lactic acidosis; avoid in severe kidney impairment and during dehydration/acute illness; monitor kidney function. Temporarily stop before iodinated contrast/surgery as advised by doctor.
